Regencell Bioscience Holdings Limited
RGC
$-0.35
Change (1 day)
$32.44
Year High
$3.03
Year Low
Categories
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience Holdings Limited (RGC) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 56.55 K | -1,101,126 | 632.32 K | 12.62 M | 11.62 M |
| 2022 | 27.6 K | -5,645,743 | 938.03 K | 18.02 M | 16.44 M |
| 2021 | 7.44 K | 3.62 M | 4.34 M | 340.13 K | 66.85 K |
| 2020 | 2.68 M | 3.16 M | 514.02 K | 386.98 K | |
| 2019 | 1.84 M | 2.08 M | 243.31 K | 243.31 K |